Tiziana Life Sciences Ltd (TLSA) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
TLSA Revenue Growth
TLSA Revenue Analysis (2013–2024)
As of May 8, 2026, Tiziana Life Sciences Ltd (TLSA) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2024) recorded $0 in revenue.
Looking at the longer-term picture, TLSA's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $3,000 in 2013.
When compared to Healthcare sector peers including ARCT (-46.4% YoY), KYMR (-12.6% YoY), and RCUS (+67.4% YoY). Compare TLSA vs ARCT →
TLSA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TLSACurrent | $0 | - | - | - | |
 ARCT | $67M | -46.4% | +47.8% | -111.5% | |
 KYMR | $39M | -12.6% | +2.9% | -891.3% | |
 RCUS | $247M | +67.4% | +25.9% | -156.3% |
TLSA Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $0 | - | $-15,794,000 | - |
| 2023 | $0 | - | $0 | - | $-17,984,000 | - |
| 2022 | $0 | - | $0 | - | $-14,586,000 | - |
| 2021 | $0 | - | $0 | - | $-27,374,000 | - |
| 2020 | $0 | - | $0 | - | $-28,026,000 | - |
| 2019 | $0 | - | $0 | - | $-7,773,000 | - |
| 2018 | $0 | - | $0 | - | $-7,824,058 | - |
| 2017 | $0 | - | $0 | - | $-8,246,000 | - |
| 2016 | $0 | - | $0 | - | $-7,288,000 | - |
| 2015 | $0 | - | $0 | - | $-8,614,000 | - |
See TLSA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TLSA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TLSA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTLSA — Frequently Asked Questions
Quick answers to the most common questions about buying TLSA stock.
Is TLSA's revenue growth accelerating or slowing?
TLSA TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is TLSA's long-term revenue growth rate?
Tiziana Life Sciences Ltd's 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is TLSA's revenue distributed by segment?
TLSA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.